DNA-Technology on KIHE-2026

May 20–22, 2026 – The 31st Kazakhstan International Healthcare Exhibition KIHE 2026 took place in Almaty. It is the largest platform in Central Asia for showcasing achievements in scientific and practical medicine.

The exhibition featured 400 companies from 16 countries. 37% of the stands were from Kazakh manufacturers, and 63% from international companies. The exposition was visited by 4,970 unique specialists: heads of medical centers, chief physicians, pharmacists, and doctors of various specialties.

 Special attention was given to reproductive health – one of the key topics in modern medicine.

The demand for accurate and timely diagnostics, which help preserve patients’ reproductive potential and increase treatment effectiveness, is growing every year.

DNA -Technology company traditionally presented its advanced diagnostic solutions in this field at KIHE 2026.

We showcased our products for assessing the reproductive health of both men and women.

A report titled “New Diagnostic Capabilities in Reproductive Medicine” was delivered by Prof. N.Katkova, MD, PhD, which sparked great interest among the professional community.

The company’s portfolio includes a broad range of test systems for diagnostics in this area, including detection of:

· Urogenital infections.

· Human papillomavirus (HPV) infections.

· Unique microbiota test systems: ANDROFLOR® (for men) and FEMOFLOR® (for women).

The visitors’ interest in microbiota research was very high, and our developments in this area are more relevant than ever.

Understanding the state of microbiota is essential for diagnosing inflammatory processes, fertility disorders, and preparing for assisted reproductive technologies.

We held productive meetings with partners, set goals, and discussed future collaboration plans.